Comparison
Ashwagandha vs. Rhodiola Rosea
Ashwagandha or rhodiola – which adaptogen is supported by evidence?
The short answer
Ashwagandha has clearly the better evidence base: several randomized trials on stress markers and cortisol, although mostly small and from a limited number of research groups. Rhodiola does not get beyond a review of eleven studies with around 446 participants, not a single one of which met the CONSORT criteria – the authors explicitly consider the evidence insufficient to judge efficacy. More important than the comparison, for ashwagandha, is a safety note: in 2024, the German Federal Institute for Risk Assessment pointed to liver damage and the hormonal effect.
The numbers side by side
| Axis | Ashwagandha | Rhodiola Rosea | Difference |
|---|---|---|---|
| Human evidenceHow much data in humans, and how good | 5 | 3 | Ashwagandha better studied |
| MechanismHow well the chain of effects is understood | 4 | 3 | Ashwagandha better studied |
| Safety dataHow well safety has been studied – not how safe it is | 5 | 4 | Ashwagandha better studied |
| Hype gap10 means: the marketing stays level with the data | 4 | 2 | Ashwagandha closer to the data |
| Track record of useHow much documented use in humans exists – does not measure whether it works | 8 | 7 | Ashwagandha in use for longer |
| Rating | Thin human evidence · Long used, barely studied | ||
“Track record of use” measures how long and how widely something has been used in humans – not whether it works. The BK-Score is a subjective assessment by Biohacking Kompakt based on published scoring rules. It is not a scientific rating, not the consensus of a professional society and not a medical recommendation.
Why these numbers
Ashwagandha
There are several RCTs on stress and cortisol, mostly small, short and close to manufacturers. The mechanism remains vague. An important point for the safety data: reports of liver damage have occupied several authorities.
Rhodiola Rosea
The systematic review (Ishaque et al., BMC Complement Altern Med 2012) summarizes 11 studies with around 446 participants: for physical fatigue, two of six studies were positive, for mental fatigue three of five – and not a single one met the CONSORT criteria. The authors' conclusion states, verbatim, that the evidence is insufficient to judge efficacy. The adaptogen concept itself, a modulation of the HPA axis, comes from animal studies and has not been confirmed in humans.
Frequently asked questions
What is an adaptogen, anyway?
The term comes from Soviet research and refers to substances that are supposed to increase resistance to stress in a nonspecific way. It is not a pharmacological category, and the assumed modulation of the stress axis is derived mainly from animal studies.
What does the BfR point out about ashwagandha?
Documented cases of liver injury, as well as the hormonal effect, which is relevant during pregnancy and breastfeeding and in thyroid disease. On our site, ashwagandha is therefore listed only with a warning.
Why does rhodiola get a low score despite many studies?
Because the axis rates quality, not quantity. Eleven studies, none of which is methodologically sound and whose results contradict each other, do not add up to a reliable conclusion.
See all 255 ratings in the ranking
Information only, not medical advice and no usage or dosing recommendation. Prescription-only and unapproved substances belong in medical hands.